Correction to Supplement 2: Misspelling of a Collaborator’s Name
-
October 19, 2026
Clinical Scorecard: Correction to Supplement 2: Misspelling of a Collaborator’s Name
At a Glance
| Category | Detail |
|---|---|
| Condition | Not specified in the correction notice |
| Key Mechanisms | Not described in the correction notice |
| Target Population | Not specified in the correction notice |
| Care Setting | Not specified in the correction notice |
Key Highlights
- Supplement 2 contained a misspelling of nonauthor collaborator Ahmet Bulent Dogrul’s name.
- The correction concerns the Original Investigation “Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms,” published March 27, 2026.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Not reported in the correction notice.
The notice identifies the original investigation as concerning contemporary adjuvant chemotherapy for IPMNs but provides no treatment details.
Clinical Best Practices
Related Resources & Content
Based on findings from:
Error in Supplement 2
Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855482
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
